Advisor Group, Inc. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2019$5,000
-58.3%
1,3750.0%0.00%
Q3 2019$12,000
-29.4%
1,375
-26.7%
0.00%
Q2 2019$17,000
-10.5%
1,875
-37.5%
0.00%
Q1 2019$19,000
+1800.0%
3,000
+8471.4%
0.00%
Q2 2018$1,0000.0%350.0%0.00%
Q1 2018$1,0000.0%350.0%0.00%
Q4 2017$1,0000.0%350.0%0.00%
Q3 2017$1,000350.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders